Search by Drug Name or NDC
NDC 55289-0660-82 temazepam 30 mg/1 Details
temazepam 30 mg/1
temazepam is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is TEMAZEPAM.
MedlinePlus Drug Summary
Temazepam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Temazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
Related Packages: 55289-0660-82Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Temazepam
Product Information
| NDC | 55289-0660 |
|---|---|
| Product ID | 55289-660_05f67adb-a0bc-189c-e063-6294a90a483d |
| Associated GPIs | 60201030000110 |
| GCN Sequence Number | 003690 |
| GCN Sequence Number Description | temazepam CAPSULE 30 MG ORAL |
| HIC3 | H21 |
| HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
| GCN | 13841 |
| HICL Sequence Number | 001592 |
| HICL Sequence Number Description | TEMAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | temazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | temazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | TEMAZEPAM |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA071457 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55289-0660-82 (55289066082)
| NDC Package Code | 55289-660-82 |
|---|---|
| Billing NDC | 55289066082 |
| Package | 500 CAPSULE in 1 BOTTLE, PLASTIC (55289-660-82) |
| Marketing Start Date | 2020-04-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |